NCT06340243View on ClinicalTrials.gov

Risk Adapted Therapy of Hodgkin Lymphoma in Upper Egypt

Not yet recruitingOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions

Pediatric Hodgkin Lymphoma

Interventions

RADIATION

radiotherapy

radiotherapy

All Listed Sponsors

lead

Assiut University

OTHER

NCT06340243 - Risk Adapted Therapy of Hodgkin Lymphoma in Upper Egypt | Biotech Hunter | Biotech Hunter